A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
NCT00420524
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignancies
Tumors
Interventions
DRUG:
Patupilone/EPO906
Sponsor
Novartis Pharmaceuticals